Related Experiment Video
Updated: Sep 26, 2025

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
Published on: September 28, 2016
Structure, gating, and pharmacology of human CaV3.3 channel
Lingli He1,2,3, Zhuoya Yu1,2,3, Ze Geng4,5
1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Abstract:
The low-voltage activated T-type calcium channels regulate cellular excitability and oscillatory behavior of resting membrane potential which trigger many physiological events and have been implicated with many diseases. Here, we determine structures of the human T-type CaV3.3 channel, in the absence and presence of antihypertensive drug mibefradil, antispasmodic drug otilonium bromide and antipsychotic drug pimozide. CaV3.3 contains a long bended S6 helix from domain III, with a positive charged region protruding into the cytosol, which is critical for T-type CaV channel activation at low voltage. The drug-bound structures clearly illustrate how these structurally different compounds bind to the same central cavity inside the CaV3.3 channel, but are mediated by significantly distinct interactions between drugs and their surrounding residues. Phospholipid molecules penetrate into the central cavity in various extent to shape the binding pocket and play important roles in stabilizing the inhibitor. These structures elucidate mechanisms of channel gating, drug recognition, and actions, thus pointing the way to developing potent and subtype-specific drug for therapeutic treatments of related disorders.
Insights
Structural insights into human T-type calcium channels (CaV3.3) reveal how diverse drugs bind to the same site. This research clarifies channel gating and drug interactions, aiding the development of targeted therapies for related diseases.
Area of Science:
- Structural biology
- Neuroscience
- Pharmacology
Background:
- Low-voltage-activated T-type calcium channels (CaV3.3) are crucial for cellular excitability and physiological events.
- Dysfunction of CaV3.3 channels is linked to various diseases.
Purpose of the Study:
- To determine the structures of the human CaV3.3 channel.
- To investigate the binding mechanisms of different drugs (mibefradil, otilonium bromide, pimozide) within the CaV3.3 channel.
- To elucidate the role of phospholipid molecules in drug binding and channel stabilization.
Main Methods:
- Cryo-electron microscopy (Cryo-EM) to determine high-resolution structures.
- Structural analysis of CaV3.3 in apo state and in complex with various drugs.
- Investigation of drug-residue interactions and the influence of phospholipids.
Main Results:
- Revealed a unique bent S6 helix in CaV3.3 critical for low-voltage activation.
- Demonstrated that structurally distinct drugs bind to the same central cavity but via different interactions.
- Identified phospholipid molecules shaping the binding pocket and stabilizing inhibitors.
Conclusions:
- The determined structures provide mechanistic insights into CaV3.3 channel gating and activation.
- Elucidated the distinct binding modes of various drugs within the CaV3.3 channel.
- These findings pave the way for designing potent, subtype-specific drugs for treating CaV3.3-related disorders.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Mechanically-gated Ion Channels
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
G-Protein Gated Ion Channels
Sensory...

